VBIVQ — VBI Vaccines Cashflow Statement
0.000.00%
Last trade - 00:00- $0.01m
- $36.16m
- $8.68m
Annual cashflow statement for VBI Vaccines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -54.8 | -46.2 | -69.8 | -113 | -92.8 |
| Depreciation | |||||
| Non-Cash Items | 11.5 | 7.67 | 12.8 | 40.2 | 41.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.63 | -10.1 | 15.2 | -2.66 | -11.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -48.7 | -47 | -39.9 | -73.7 | -60.9 |
| Capital Expenditures | -3.67 | -1 | -2 | -4.34 | -0.867 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -25 | 25.2 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.67 | -26 | 23.2 | -4.34 | -0.867 |
| Financing Cash Flow Items | -2.83 | -6.63 | -1.09 | -0.563 | -1.57 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 37.4 | 122 | 44.3 | 19.4 | 22.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.1 | 49.6 | 27.9 | -59.1 | -38.9 |